SCHEMBL24136122

SCHEMBL24136122

CCNC(=O)C(C)(CC)CC(C)(C)C(N)=O

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17814159 0.80 MMP1 (0.37) RIPK1
SCHEMBL12890819 0.76
SCHEMBL13009945 0.76
SCHEMBL12385186 0.76
SCHEMBL14556928 0.73 EPHX1 (0.30)
SCHEMBL17883165 0.72 ALDH1A1 (0.35) RIPK1
SCHEMBL12890759 0.71 KDM4E (0.30)
SCHEMBL5021619 0.71 RIPK1 (0.52) RIPK1
SCHEMBL24801384 0.69 RIPK1 (0.33) RIPK1
SCHEMBL13624772 0.69 DGAT1 (0.31) RIPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3929217-A2 SPECIFIC SITES FOR MODIFYING ANTIBODIES TO MAKE IMMUNOCONJUGATES Novartis AG (CH) 2021-12-29 EP disclosed